Image-Guided Interventional Oncology (IGIO) Market Is Expected To Grow Due To Rapid Advancements In Medical Imaging Technology

According to Precision Business Insights' (PBI) latest report, the image-guided interventional oncology (igio) market is expected to be valued at 772.7('000) Procedure in 2023, growing at an 8.1% CAGR from 2023 to 2029. Interventional procedures are commonly used for soft tissue carcinomas, including those in the liver, breast, lungs, kidneys, and prostate. They are also increasingly used for other types of cancer, such as pancreatic, brain, and bone cancers. As minimally invasive procedures become more popular, patients and doctors opt for interventional procedures. These procedures, along with advanced imaging technology, are transforming cancer treatment. Imaging techniques like fluoroscopy, ultrasonography, CT scans, and MRI are used to guide the placement of probes, apply energy with precision, improve treatment outcomes, and modify treatment plans.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/image-guided-interventional-oncology-market

The image-guided interventional oncology (igio) market is segmented based on cancer type, indication, image technology, end user, and geography.
Based On the Cancer Type:
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Liver Cancer
• Kidney Cancer
• Others

Based On the Indication:
• Cancer Diagnosis
• Portal Vein Embolization
• Cancer Treatment
• Management of Cancer Complication

Based On the Image Technology:
• Computed Tomography
• Ultrasound
• Magnetic Resonance Imaging
• Fluroscopy
• X-rays

Based On the End-User:
• Hospitals and Diagnostic Centers
• Ambulatory Surgical Centers
• Academic and Research Institutes

Based On the Geography:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

IGIO Procedures Are Expected To Be Used Mostly For The Treatment Of Cancer, And CT Is Expected To Hold The Largest Share In The IGIO Proceedings:
In 2018, 255.5 thousand cancer treatment procedures were performed using Image-Guided Interventional Oncology. According to the World Health Organization, cancer is the second leading cause of death worldwide. In 2020, there were an estimated 9.5 million cancer deaths. CT is a type of medical imaging that uses X-rays to create detailed images of the inside of the body. This makes it a valuable tool for diagnosing cancer, as it can help to identify tumors and other abnormalities. CT can also be used to plan cancer treatment, such as surgery or radiation therapy. In addition to its diagnostic capabilities, CT can also be used to deliver cancer treatment. For example, CT-guided biopsies can be used to collect tissue samples from tumors for analysis. CT-guided radiation therapy can be used to deliver high-dose radiation to tumors while minimizing the dose to surrounding tissues. As a result of its versatility and safety, CT is expected to hold the largest share in the IGIO proceedings. Some additional scientific facts about why IGIO procedures are expected to be used mostly for the treatment of cancer are CT is a very sensitive imaging modality, which means that it can detect small tumors that may not be visible with other imaging methods. CT is a relatively quick and easy procedure, which makes it a good option for cancer patients who may be too sick for more invasive procedures. CT is a relatively safe procedure with few side effects. Overall, CT is a valuable tool for the diagnosis and treatment of cancer. It is expected to play a major role in IGIO procedures, which are promising new approaches to cancer treatment.

Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=535987

North American Region to Dominate the Image-Guided Interventional Oncology (IGIO) Market:
The United States may have a lower elderly population compared to other countries, but the median age of Americans is rapidly increasing, leading to a rise in cancer incidence. Shockingly, breast cancer accounted for a whopping x% of all interventional oncology procedures in 2020, with 276,480 cases reported. Close on its heels was lung cancer, with an incidence rate of 228,000 in 2022. Cryoablation and drug combinations have emerged as the most effective treatments, backed by scientific literature that proves their worth. Cryoablation weakens tumor cells, while combination therapy leads to long-lasting increases in immune system cells that attack tumors. Excitingly, CT scans have proven to be a valuable tool, with intra-procedural volumetric imaging providing superior visibility. And as if that wasn't enough, the cancer treatment segment accounted for a substantial proportion of all interventional oncology procedures in 2022, with ablation procedures like radiofrequency and microwave ablation becoming standard. To top it all off, the management of cancer-related pain is also a significant aspect of interventional oncology. By collaborating with radiation oncologists, interventional oncologists can revolutionize cancer treatment and improve outcomes for patients.

Strategic New Product Launches, Mergers, Acquisitions, And Agreements Are The Key Strategies Adopted By Market Players:
The global tunable diode laser market further reveals that the key players are increasingly adopting strategies such as launching newer products and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In April 2023, GE Healthcare announced that it is advancing its precision care strategy with CT-Navigation. This technology provides clinicians with real-time, detailed 3D computed tomography (CT) images. It can be used for stereotactic needle guidance in a variety of care areas, including biopsies, ablations, drainage, therapeutics, and oncological and interventional procedures. In March 2023, At the European Congress of Radiology (ECR) international meeting (March 1-5, Vienna, Austria), Royal Philips showcased its radiology portfolio of smart connected imaging systems and vendor-neutral integrated radiology workflow solutions. At Philips @The Blue Level, the largest exposition space at the Congress, attendees witnessed how Philips' AI-powered technology transforms data into actionable insights that boost diagnostic confidence and improve clinical outcomes. This technology enhances the patient and staff experience, drives operational efficiency, and reduces the cost of care.

Key Players in the image-guided interventional oncology (igio) market are Boston Scientific Corporation, Teleflex, Terumo Corporation, Cook Medical, HealthTronics Inc., IMBIOTECHNOLOGIES LTD, Medtronic, MedWaves, Inc, Merit Medical Systems, GE HealthCare, Sanarus Technologies LLC

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.